191 related articles for article (PubMed ID: 31822277)
1. Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study.
Yang W; Chen Y; Huang Y; Wang H
BMC Pediatr; 2019 Dec; 19(1):485. PubMed ID: 31822277
[TBL] [Abstract][Full Text] [Related]
2. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.
Zhi T; Zhang WL; Zhang Y; Hu HM; Huang DS
BMC Pediatr; 2021 Apr; 21(1):170. PubMed ID: 33849474
[TBL] [Abstract][Full Text] [Related]
5. Independent Assessment of the Children's Hepatic Tumors International Collaboration Risk Stratification for Hepatoblastoma and the Association of Tumor Histological Characteristics With Prognosis.
Zhou S; Malvar J; Chi YY; Stein J; Wang L; Genyk Y; Sposto R; Mascarenhas L
JAMA Netw Open; 2022 Feb; 5(2):e2148013. PubMed ID: 35147687
[TBL] [Abstract][Full Text] [Related]
6. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognostic analysis of hepatoblastoma in children under six years old].
Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1063-1068. PubMed ID: 34933424
[No Abstract] [Full Text] [Related]
8. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.
Wang TY; Han YL; Gao YJ; Xu M; Gu S; Yin MZ; Zhong YM; Hu WT; Pan C; Tang JY
Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):471-478. PubMed ID: 31000431
[TBL] [Abstract][Full Text] [Related]
11. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognosis of 83 children with newly treated hepatoblastoma].
Wei LL; Ran Y; Li B; Su SF; Wei HX; Mao ST; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Feb; 60(2):108-113. PubMed ID: 35090226
[No Abstract] [Full Text] [Related]
13. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
Sunil BJ; Palaniappan R; Venkitaraman B; Ranganathan R
J Gastrointest Cancer; 2018 Dec; 49(4):493-496. PubMed ID: 28963691
[TBL] [Abstract][Full Text] [Related]
14. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
Kubota M; Yagi M; Kanada S; Yamazaki S; Tanaka S; Asami K; Ogawa A; Watanabe A; Iwabuchi H; Kaneko M; Saida Y
J Pediatr Surg; 2004 Dec; 39(12):1775-8. PubMed ID: 15616926
[TBL] [Abstract][Full Text] [Related]
15. Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report.
Aronson DC; Weeda VB; Maibach R; Czauderna P; Dall'Igna P; de Ville de Goyet J; Branchereau S; Perilongo G; Brock P; Zsiros J; Semeraro M; Chardot C; Wildhaber B; Morland B; Brugières L;
Eur J Cancer; 2019 Jan; 106():126-132. PubMed ID: 30528797
[TBL] [Abstract][Full Text] [Related]
16. [A follow-up report of childhood hepatoblastoma from 74 cases in a single center].
Wang TY; Pan C; Tang JY; Ye QD; Zhou M; Gao YJ; Hu WT
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):364-368. PubMed ID: 28482388
[No Abstract] [Full Text] [Related]
17. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing recurrence after complete remission in children with hepatoblastoma: A 14-year retrospective study in China.
Li F; Zhang W; Hu H; Zhu X; Zhang Y; Huang D
PLoS One; 2021; 16(11):e0259503. PubMed ID: 34843510
[TBL] [Abstract][Full Text] [Related]
20. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]